We recently published a list of 10 Stocks To Trade Without Tariffs And Interest Rate Fears. In this article, we are going to ...

Goldman Sachs has lifted its gold forecast again, as investors and central banks keep buying the yellow metal.

Wall Street ended lower on Wednesday, weighed down by renewed trade concerns after reports suggested the US administration ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

Goldman Sachs on Tuesday bought shares of auto components major Samvardhana Motherson International for Rs 87 crore through ...

The healthcare startup raised fresh Series C funding for its AI that helps clinics aggregate patient data to deliver better ...

US stocks surged with strong gains in tech, banking, and airline sectors. Investors welcomed reports of scaled-back tariffs, fueling a bullish market mood.

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...

Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) have been assigned an average rating of “Hold” from the twenty-four ...

Moderna (NASDAQ:MRNA – Get Free Report) had its price objective lowered by analysts at JPMorgan Chase & Co. from $40.00 to ...

Danaher (NYSE:DHR) traded higher in the premarket on Friday after Goldman Sachs upgraded the life sciences company to Buy ...

Goldman Sachs analyst Chris Shibutani maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $136.00.